These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7184358)

  • 1. [Evaluation of the therapeutic effect of HCFU (1-hexylcarbamoyl-5-fluorouracil) on non-resectable stomach cancer].
    Sato H; Satoh H; Isono K; Onoda S; Okuyama K; Tounosu N; Yamamoto Y; Kimura M; Chin F; Kouzu T; Ryu M; Hirasawa H
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):103-8. PubMed ID: 7184358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].
    Shiraishi K; Kubo Y; Majima Y; Sato K; Sakemi T; Sakai T; Hirai K; Ninomiya F; Abe M; Tanikawa K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2348-55. PubMed ID: 6093712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-hexylcarbamoyl-5-fluorouracil on spontaneous mammary adenocarcinoma of mice.
    Tokuzen R; Iigo M; Hoshi A; Kuretani K
    Gan; 1980 Oct; 71(5):724-8. PubMed ID: 7227721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice.
    Kubota T; Kase S; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Nishibori H; Ishibiki K; Kitajima M; Mabuchi K
    Anticancer Res; 1992; 12(5):1549-53. PubMed ID: 1444220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of a new antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), administered orally: an HCFU clinical study group report.
    Koyama Y; Koyama Y
    Cancer Treat Rep; 1980; 64(8-9):861-7. PubMed ID: 7448823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic study on canine gastric cancer induced by N-ethyl-N'-nitro-N-nitrosoguanidine.
    Matsukura N; Aoyagi M; Kawachi T; Uchida E; Yoshida S; Hirashima T; Takasugi T; Ushio K; Hirota T; Sugimura T
    Gan; 1980 Jun; 71(3):349-55. PubMed ID: 7418981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].
    Misaki T; Hisazumi H; Sakai A; Nakamura T; Kanda S; Mikawa I; Miyagi T; Katsumi T; Orito M; Kawaguchi K
    Hinyokika Kiyo; 1985 Jul; 31(7):1233-41. PubMed ID: 3933287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer.
    Sugimachi K; Maehara Y
    Surg Today; 2000; 30(12):1067-72. PubMed ID: 11193737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [1-Hexylcarbamoyl-5-fluorouracil (HCFU) effective in hepatocellular carcinoma metastatic to the lungs--a case report].
    Higashi H; Takenaka K; Kanematsu T; Matsumata T; Yoshida Y; Sugimachi K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2956-9. PubMed ID: 2821925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effect of HCFU therapy of head and neck cancer].
    Taketa C
    Gan To Kagaku Ryoho; 1986 May; 13(5):1846-50. PubMed ID: 3707146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis in metastatic foci from human gastric cancer xenografts in nude mice and reduction of circulating tumor cells in blood by 5-FU and 1-hexylcarbamoyl-5-fluorouracil.
    Nakanishi H; Abe A; Inada K; Tsukamoto T; Yasui K; Tatematsu M
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):660-8. PubMed ID: 10592098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of hepatocellular carcinoma (HCC) with lung metastasis which responded to chemotherapy with a single use of 1-hexylcarbamoyl-5-fluorouracil (HCFU)].
    Kanda Y; Akazawa S; Futatsugi K; Fujiki T; Saifuku K; Yamamoto K; Suzuki F; Nakajima T; Naoi Y; Muraoka M
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):269-72. PubMed ID: 2537606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral HCFU for prevention of hepatic metastasis in an experimental colorectal carcinoma.
    Ito K; Wang L; Ye C; Ando H; Hibi K; Hidemura K; Akiyama S; Kasai Y; Nakao A
    Anticancer Res; 2001; 21(2A):899-904. PubMed ID: 11396182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
    Akiharu W; Higashi T; Kobayashi M; Nakatsukasa H; Fujiwara M; Shiota T; Yamauchi Y; Ito T; Yamamoto H; Nagashima H
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2506-12. PubMed ID: 6095760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of HCFU and radiation therapy for head and neck cancer].
    Honda T
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):799-804. PubMed ID: 6881999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II study of carmofur (HCFU) fine granules].
    Koyama Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):906-14. PubMed ID: 7184433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil.
    Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Chemother Pharmacol; 1980; 4(2):83-7. PubMed ID: 7389060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum concentration of HCFU and 5-FU after oral administration of HCFU in postoperative digestive cancer patients].
    Kuroda Y; Ohkuma R; Ohsato K
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1831-6. PubMed ID: 1519925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
    Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
    Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.